Literature DB >> 28640449

Polycystic Kidney Disease.

Joseph Ghata1, Benjamin D Cowley1.   

Abstract

Renal cysts, which arise from renal tubules, can be seen in a variety of hereditary and nonhereditary entities. Common mechanisms associated with renal cyst formation include increased cell proliferation, epithelial fluid secretion, and extracellular matrix remodeling. Hereditary polycystic kidney disease (PKD) is seen as a component of numerous diseases. Autosomal dominant (AD) PKD is the most common potentially fatal hereditary disease in humans, causes renal failure in approximately 50% of affected individuals, and accounts for approximately 5% of end stage renal disease cases in the United States. ADPKD is caused by mutation in one of two genes-85% of cases are caused by mutation in PKD1 on chromosome 16 and 15% of cases are caused by mutation in PKD2 on chromosome 4. Polycystin-1, encoded by PKD1, is a large protein, has multiple transmembrane spanning domains, has extracellular regions suggesting a role in cell-cell or cell-matrix interactions, has intracellular domains suggesting a role in signal transduction, and can physically interact with Polycystin-2. Polycystin-2 is smaller, has transmembrane domains, can act as a cation channel with calcium permeability, and may be regulated by Polycystin-1. These proteins, and many others associated with cystic kidney disease, localize to primary cilia, which may act as flow sensors in the kidney; cystic kidney diseases have also been termed ciliopathies. An increasing number of intracellular mechanisms, which are abnormally regulated in PKD, have been described and are potential targets for therapy, which is lacking in this common hereditary disease. © 2017 American Physiological Society. Compr Physiol 7:945-975, 2017.
Copyright © 2017 John Wiley & Sons, Inc.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28640449     DOI: 10.1002/cphy.c160018

Source DB:  PubMed          Journal:  Compr Physiol        ISSN: 2040-4603            Impact factor:   9.090


  17 in total

1.  A new coupling of an acid-base transporter to PKD and cyst formation.

Authors:  Mark O Bevensee
Journal:  J Physiol       Date:  2018-12-17       Impact factor: 5.182

2.  Cyclooxygenase 2 inhibition slows disease progression and improves the altered renal lipid mediator profile in the Pkd2WS25/- mouse model of autosomal dominant polycystic kidney disease.

Authors:  Md Monirujjaman; Harold M Aukema
Journal:  J Nephrol       Date:  2019-01-22       Impact factor: 3.902

3.  MICAL-L1 coordinates ciliogenesis by recruiting EHD1 to the primary cilium.

Authors:  Shuwei Xie; Trey Farmer; Naava Naslavsky; Steve Caplan
Journal:  J Cell Sci       Date:  2019-11-14       Impact factor: 5.285

Review 4.  Polycystic Liver Disease: Pathophysiology, Diagnosis and Treatment.

Authors:  Luiz Fernando Norcia; Erika Mayumi Watanabe; Pedro Tadao Hamamoto Filho; Claudia Nishida Hasimoto; Leonardo Pelafsky; Walmar Kerche de Oliveira; Ligia Yukie Sassaki
Journal:  Hepat Med       Date:  2022-09-29

5.  The predictive value of renal parenchymal information for renal function impairment in patients with ADPKD: a multicenter prospective study.

Authors:  Yuhang Xie; Mengmiao Xu; Yajie Chen; Xiaolan Zhu; Shenghong Ju; Yuefeng Li
Journal:  Abdom Radiol (NY)       Date:  2022-05-28

6.  Prothymosin α promotes STAT3 acetylation to induce cystogenesis in Pkd1-deficient mice.

Authors:  Yi-Cheng Chen; Yu-Chu Su; Gia-Shing Shieh; Bing-Hua Su; Wen-Cheng Su; Pei-Hsin Huang; Si-Tse Jiang; Ai-Li Shiau; Chao-Liang Wu
Journal:  FASEB J       Date:  2019-10-05       Impact factor: 5.191

7.  Identification of a pathogenic mutation in a Chinese pedigree with polycystic kidney disease.

Authors:  Kexian Dong; Huanhuan Miao; Xueyuan Jia; Jie Wu; Han Wu; Jiawei Sun; Wei Ji; Hui Su; Lidan Xu; Xuelong Zhang; Siqi Zhu; Guohua Ji; Rongwei Guan; Hao Wang; Jing Bai; Jingcui Yu; Wenjing Sun; Xianli Zhou; Songbin Fu
Journal:  Mol Med Rep       Date:  2019-01-31       Impact factor: 2.952

8.  Expression and secretion of CXCL12 are enhanced in autosomal dominant polycystic kidney disease.

Authors:  Hyunho Kim; Jinmo Sung; Hyunsuk Kim; Hyunjin Ryu; Hayne Cho Park; Yun Kyu Oh; Hyun-Seob Lee; Kook-Hwan Oh; Curie Ahn
Journal:  BMB Rep       Date:  2019-07       Impact factor: 4.778

Review 9.  The Utility of Human Kidney Organoids in Modeling Kidney Disease.

Authors:  Aneta Przepiorski; Amanda E Crunk; Eugenel B Espiritu; Neil A Hukriede; Alan J Davidson
Journal:  Semin Nephrol       Date:  2020-03       Impact factor: 5.299

10.  Genetic Effects on Dispersion in Urinary Albumin and Creatinine in Three House Mouse (Mus musculus) Cohorts.

Authors:  Guy M L Perry
Journal:  G3 (Bethesda)       Date:  2019-03-07       Impact factor: 3.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.